From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil driven diseases

Journal article

Open access

Peer reviewed

Ian Pavord, Elisabeth Bel, Arnaud Bourdin, Robert Chan, Joseph Han, Oliver Keene, Mark Liu, Neil Martin, Alberto Papi, Florence Roufosse, …

Allergy

2021

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1111/all.15056View

Published (Version of record) Open

1 Record Views

Title: From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil driven diseases
Creators - without role: Ian Pavord - University of Oxford
Elisabeth Bel - Amsterdam University Medical Centers
Arnaud Bourdin - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Robert Chan - GlaxoSmithKline
Joseph Han - Eastern Virginia Medical School
Oliver Keene - MRC Biostatistics Unit
Mark Liu
Neil Martin - University of Leicester
Alberto Papi - University of Ferrara
Florence Roufosse - Erasmus Hospital
Jonathan Steinfeld - GlaxoSmithKline
Michael Wechsler - National Jewish Health
Steven Yancey - Research Triangle Park Foundation
Publication Details: Allergy
Identifiers: 9936752709311
Academic Unit: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Language: English
Resource Type: Journal article
Local Fields: hal-03326833